Assessment of serum nitrate-nitrite ratio vis-a-vis insulin sensitivity and resistance in type 2 diabetics in a tertiary hospital in Eastern India
DOI:
https://doi.org/10.18203/2320-6012.ijrms20164555Keywords:
Insulin resistance, Insulin sensitivity, Serum nitrate-nitrite ratio, Type 2 diabetes mellitusAbstract
Background: Insulin Resistance is of paramount importance in the pathophysiology of Type 2 Diabetes Mellitus along with endothelial dysfunction is mediated by Nitric Oxide (NO). Central to this endothelial dysfunction is the action of Insulin on the Nitric oxide synthase enzyme. Since NO cannot be measured because of its short half-life, metabolites of NO (namely nitrite and nitrate) are measured towards assessing their relationship along with different direct and surrogate markers of insulin resistance in patients of Diabetes Mellitus attending a tertiary care hospital in Eastern India. Aim of the study was to assess the level of Insulin resistance with the direct and surrogate markers of insulin resistance in patients of Diabetes Mellitus attending a tertiary care hospital in Eastern India.
Methods: Blood samples from newly diagnosed Type 2 Diabetic patients were assayed for fasting and postprandial sugar and insulin, lipid profile and serum nitrate and nitrite and different anthropological parameters were measured. After that, HOMA-IR and QUICKI’ index were measured.
Results: Values of anthropological parameters and the direct and surrogate markers of insulin resistance showed statistically significant difference between cases and controls. Bivariate analysis of post-prandial blood glucose showed strong co-relation with HOMA-IR while serum total nitrate-nitrite ratio showed a strong co-relation with QUICKI.
Conclusions: Serum nitrate-nitrite ratio showed a strong co-relation with HOMA-IR and QUICKI. The significance of this study lies in the fact that measurement of the serum nitrate-nitrite may give an idea of the level of insulin resistance of a diabetic patient.References
Thippeswamy T, McKay JS, Quinn JP, Morris R. Nitric oxide, a biological double-faced janus-is this good or bad? Histol Histopathol. 2006;21:445-58.
Zuckerbraun BS, Stoyanovsky DA, Sengupta R, Shapiro RA, Ozaniuch BA, Rao J, et al. Nitric oxide-induced inhibition of smooth muscle cell proliferation involves S-nitrosation and inactivation of Rho A. Am J Physiol. 2007;292:C824-31.
Binion DG, Fu S, Ramanujam KS, Chai YC, Dweik RA, Drazba JA, et al. iNOS expression in human intestinal microvascular endothelial cells inhibits leucocyte adhesion. Am J Physiol. 1998;275:G592-603.
DeFronzo RA, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and ASCVD. Diabetes Care. 1991;14:173-94.
Duplain H, Burcelin R, Sartori C, Cook S, Egli M, Lepori M, et al. Insulin resistance, hyperlipemia, and hypertension in mice lacking endothelial nitric oxide synthase. Circulation. 2001;104:342-5.
Schnyder B, Pitter M, Durand J, Schnyder-Canadrian S. Rapid effects of glucose on the insulin signaling of endothelial NO generation and epithelial Na transport. Am J Physiol Endocrinol Metab. 2002;282:E87-94.
Laakso M, Edelman SV, Brechtel G, Baron AD. Decreased effect of insulin to stimulate skeletal muscle flow in obese men. J Clin Invest. 1990;85:1844-52.
Anderson EA, Hoffman RP, Balon TW, Sinkey CA, Mark Al. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest. 1991;87:2246-52.
Steinberg JO, Brechtel G, Johnson A, Fineberg N, Baron AD. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent: a novel action of insulin to increase nitric oxide release. J Clin Invest. 1994;94:1172-9.
Katz A, Sridhar SN. Quantitative insulin sensitivy check index. A simple accurate method for assessing insulin sensitivity in humans. J Clinical Endocrinol Metab. 2000;85:2402-10.
Bergman RN. Hope ID. Assessment of insulin sensitivity in vitro: a clinical review. Diabetic Metab Rev. 1989;5:411-29.
Cortas NK, Wakid NW. Determination of inorganic nitrate in serum and urine. A kinetic Cadmium reduction method. Clin Chem. 1990;36(8 Pt1):1440-3.
Bonora Kiiechl S. Prevalence of insulin resistance in metabolic disorders. The Bruneck Study. Diabetes. 1998;47:1643-9.
Warren JH, Martin BC, Krowlewski AS. Slow glucose removal of Type 2 DM in the offspring of Diabetic patients. Ann Internal Medicine. 1990;113:909-95.
Lilloja S, Molt DM, Howard BV. Impaired glucose tolerance as a disorder of insulin action. Longitudnal and cross-sectional studies in Pima Indians. N England J Med. 1998;318:1217-25.
Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK. Cardiovascular risk factors in confirmed prediabetic individuals: does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA. 1990;263:2893-8.
Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-9.
Hsueh WA, Quinones MJ, Creager MA. Endothelium in insulin resistance and diabetes. Diabetes Re. 1997;5:343-52.
Vallance P, Patton S, Bhagat K, MacAllister R, Radomski M, Moncada S, et al. Direct measurement of nitric oxide in human beings. Metabolism. 1995;49:959-61.
Kawakatsu M, Ishihara T, Kani K, Nakagawa A, Hiura M, Hazui H, et al. Plasma nitrate/nitrite concentration in healthy population and patients with Diabetes Mellitus-Relationships with gender, aging and diabetic complications. Bulletin of the Osaka Medical College. 2002;48(1,2):1-6.
Moncada S, Palmer RM, Higgs EA. The discovery of nitric oxide as the endogenous vasodilator. Hypertension. 1998;12:365-72.
Nathan C, Xie Q. Regulation of biosynthesis of NO. J Biol Chem. 1994;269:13725-8.
